MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.

De Rosa, Giusy; Russo, Claudia; Garavelli, Silvia; Di Silvestre, Dario; Spatocco, Ilaria; Mele, Giorgia; La Rocca, Claudia; Colamatteo, Alessandra et al. · Sci Transl Med · 2025

basic_science · Level V

Where this comes from

Abstract

CD4<sup>+</sup>CD25<sup>hi</sup>FoxP3<sup>+</sup> regulatory T cells (T<sub>reg</sub> cells) are key controllers of immune self-tolerance, and their suppressive function is impaired in people with relapsing-remitting multiple sclerosis (pwRR-MS). Because the mechanisms underlying this condition are still ill-defined, we investigated the role of T<sub>reg</sub> cell-derived extracellular vesicles (T<sub>reg</sub>-EVs) in T<sub>reg</sub> cell dysfunction observed in pwRR-MS. We found that T<sub>reg</sub>-EVs from healthy individuals inhibit CD4<sup>+</sup> conventional T (T<sub>conv</sub>) cells by shuttling miR-142-3p from the T<sub>reg</sub> cell to the T<sub>conv</sub> cell. There, miR-142-3p down-regulated mRNAs necessary for T<sub>conv</sub> cell growth and effector functions, such as the redox controller cystine carrier <i>SLC7A11</i>. However, T<sub>reg</sub> cells from pwRR-MS released EVs containing reduced amounts of miR-142-3p, resulting in impaired suppressive function. Furthermore, T<sub>reg</sub>-EV miR-142-3p inversely correlated with the disability score and gadolinium-enhancing lesions in pwRR-MS. Together, our results elucidate a molecular mechanism involving miR-142-3p shuttled by T<sub>reg</sub>-EVs in the control of immune self-tolerance and unveil its pathogenetic implications in human autoimmunity.

Medical subject headings